Biologic therapy in refractory neurobehçet's disease: a multicentre study of 41 patients and literature review.

Alba Herrero-MorantJosé Luis Martín-VarillasSantos CastañedaOlga MaízJulio Sánchez MartínNorberto OrtegoEnrique RayaÁgueda Prior-EspañolClara MorianoRafael B Melero-GonzálezJenaro Graña-GilAna Urruticoechea-AranaÁngel Ramos-CalvoMarta Loredo-MartínezEva Salgado-PérezFrancisca SiveraIgnacio TorreFrancisco Javier NarváezJosé Luis AndreuOlga Martínez-GonzálezRicardo Gómez-de la TorreSabela Fernández-AguadoSusana Romero-YusteÍñigo González-MazónCarmen Álvarez-RegueraJose Luis Hernández-HernándezMiguel Ángel González-GayRicardo Blanco-Alonsonull null

Published in: Rheumatology (Oxford, England) (2022)

BT appears to be effective and relatively safe in refractory NBD.

Keyphrases

rheumatoid arthritis
case report
clinical trial
study protocol
stem cells
mesenchymal stem cells
replacement therapy